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Abstract
Background: Mutagenesis screens in the mouse have been proven useful for the identification of novel gene functions and
generation of interesting mutant alleles. Here we describe a phenotype-based screen for recessive mutations affecting
embryonic development.
Methodology/Principal Findings: Mice were mutagenized with N-ethyl-N-nitrosurea (ENU) and following incrossing the
offspring, embryos were analyzed at embryonic day 10.5. Mutant phenotypes that arose in our screen include cardiac and
nuchal edema, neural tube defects, situs inversus of the heart, posterior truncation and the absence of limbs and lungs. We
isolated amongst others novel mutant alleles for Dll1, Ptprb, Plexin-B2, Fgf10, Wnt3a, Ncx1, Scrib(Scrib, Scribbled homolog
[Drosophila]) and Sec24b. We found both nonsense alleles leading to severe protein truncations and mutants with single-
amino acid substitutions that are informative at a molecular level. Novel findings include an ectopic neural tube in our Dll1
mutant and lung defects in the planar cell polarity mutants for Sec24b and Scrib.
Conclusions/Significance: Using a forward genetics approach, we have generated a number of novel mutant alleles that are
linked to disturbed morphogenesis during development.
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Introduction
In the developing embryo common molecular pathways are
used to generate different cell types, tissues and organs. Although
many of these pathways are reasonably well understood, not all of
their components are known. Genetic approaches have been of
decisive importance in discovery of these factors. Originally,
genetic analysis depended on mutations occurring accidentally,
but during the last two decades researchers have become less
dependent on chance as reverse genetic approaches using targeted
gene knock-out strategies have been used to study gene function in
the mouse [1]. At the same time, the efficiency of forward
mutagenesis screens has increased thanks to technical develop-
ment, making it applicable not only to micro-organisms and
invertebrates but also to more complex organisms.
While in principle reverse genetics makes possible any
imaginable mutation, it is laborious, based on assumptions on a
gene’s function, and may result in an organism with no detectably
affected phenotype. On the other hand, a forward genetics
approach is unbiased, technically relatively simple and avoids the
risk of an unproductive lack of interesting phenotype by selecting
affected phenotypes. Moreover, the commonly used chemical
mutagen, ENU induces point mutations, frequently leading to
hypomorphic phenotypes. Hypomorphic mutations are often
informative even for functions of genes of which previously null
mutants have been described. Moreover, these point mutations
often result in only slightly modified proteins, making the mutant
studies informative at a molecular/biochemical level. Advances in
sequencing technology are among the most important factors that
have contributed to the feasibility of forward screens in complex
organisms. The introduction of high-throughput sequencing
techniques and the development of databases containing genomic
sequences and single nucleotide polymorphism (SNP) of several
inbred mouse strains have allowed the generation of SNP panels
that facilitate efficient mapping of mutants and subsequent gene
identification by sequence analysis.
In a number of different labs mouse forward screens have been
conducted and shown to be a fruitful method for the identification
of novel gene functions even in mouse [2,3,4,5,6]. After
administration of the mutagen N-Ethyl-N-nitrosourea (ENU) high
mutation rates occur in the pre-meiotic spermatogonial stem cells,
[7]. ENU acts by transferring its ethyl group onto the bases,
transitions at A-T base pairs being the most commonly found
mutations [4,8]. In many cases these screens were performed
genome-wide, whereas in other cases they were aimed at a specific
genomic region e.g, [9]. An unavoidable aspect of screens in the
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e19357mouse, it being a viviparous organism, is the choice one has to
make of the embryonic stage of analysis. The seminal screen of
Kasarskis et al. [10] focused on embryonic day 9.5 embryos, while
in the screen by Herron et al. [11] fetuses of E18.5 day were
analyzed. While early-lethal mutations do not show up in the latter
screen, in the former no mutants with phenotypes that become
evident at later stages are detected. A different approach to further
focusing on specific potential phenotypes was applied by Zarbalis
et al. [5], who used disturbed expression of a Dlx5/6-LacZ
transgene as screening criterion.
In the present paper we describe a genome-wide screen aimed
at the identification of mutations affecting mouse development, in
which we have chosen stage E10.5 for analysis. Although this is
only one day later than in the screen of Kasarskis et al.[10], we
identified a comparatively quite different set of mutants.
We identified novel gene functions and isolated a series of novel
mutant alleles for genes that were previously linked to mutant
phenotypes. Three mutants isolated in this screen have been
published elsewhere [12,13].
Results
Identified mutants
We analyzed the offspring of 150 G1 founders at embryonic day
(E) 10.5 (Figure 1), a crucial stage for the development of the heart,
limbs and neural tube. We identified at least 25 mutant lines
characterized by a variety of reproducible phenotypes, including
cardiac and nuchal edema, neural tube defects, a truncated
anterior-posterior axis, situs inversus or the absence of limbs and
lungs (Table 1; Figure 2). An exact number of mutant lines
obtained is hard to give, as we terminated analysis of a number of
potentially genuine mutant lines when mapping data were too
confusing or reproducibility of the phenotype was doubtful.
Therefore we can only give a minimum estimate. Amongst the
mutants described included in Table 1 are several for which we
have not yet identified the causative mutation.
Optimal ENU induction in mice is expected to lead to a
mutation rate of approximately one mutation per 1.5 mega base
pairs (Mbp) [14]. Based on this mutation rate, a size of the mouse
genome of approximately 2.5610
3 Mbp and assuming that
approximately 1.5% of the genome encodes a protein, we
anticipate that each G1 founder contains about 25 mutations that
affect protein sequence.
A substitution mutation in Dll1 leads to disturbed left-
right patterning and axial truncation in 59459-2 mutants
A mutant characterized by a short tail as well as heart defects
including situs inversus (Figure 3A), was mapped to Chromosome
(Chr) 17 (5.5–27.5 Mbp). Exons of genes in this interval were
sequenced, which resulted in the discovery of an A to G transition
(Figure 3B) in the gene encoding the Notch DSL ligand Delta-like1
(Dll1). This mutation, Dll1
E26G, causes a glutamine-to-glycine
substitution at amino acid position 26 (ENSMUSG00000014773).
Glutamine 26 is highly conserved between species as well as in the
Dll1-related protein Jagged/Serrate [15] and is positioned in the
N-terminal domain 1 of the protein (Figure 3C).
Dll1 is known to be required for the formation and identity
maintenance of the caudal somites [16] and for left-right asymmetry
in the embryo [17]. Dll1 expression starts during the mid-streak
stage in embryonic mesoderm. In the late-streak embryo expression
is restricted to the posterior mesoderm, but it is absent from the
node. At the 5-somite stage it is expressed in the presomitic
mesoderm, the caudal halves of the condensed somites and in the
neuroepithelium of the presumptive midbrain region [18].
Dll1
E26G mutant embryos were posteriorly truncated (Figure 3A).
Similar shortened anteroposterior axes have been previously
reported for Dll1 mutants by Hrabe ´ de Angelis et al. [19]. In
addition the neural tube and the somites were irregularly shaped
in the posterior part of mutant embryos (Figure 3H,I). Interest-
ingly, an ectopic neural tube was occasionally present in
Dll1
E26Gmutant embryos, ventrally of the primary neural tube
and dorsally of the notochord (Figure 3F,G). Tbx6 mutant embryos
often display an ectopic neural tube, which is accompanied by
decreased levels of Dll1 expression in the mesoderm [20]. We are
however not aware of similar reports for the Dll1 mutant itself.
Finally, we observed randomized heart looping in Dll1
E26G mutant
embryos (Figure 3D,E) as previously noted by Przemeck et al. [17]
for the previously characterized Dll1 mutant.
Notch signaling has been implicated in the development of the
left-right axis, and heart looping and turning of the embryoare
randomized in Dll1 mutants. This phenotype originates from the
node, which displays morphological abnormalities in these mutants,
including loss of monociliated cells [17]. The strong resemblance to
the known knock-out null phenotype that the Dll1
E26G embryos
display indicates that the amino acid substitution observed is
sufficient to abolish most or all of the biological function of the
protein. A likely explanation is that Dll1E26 is essential in the
binding of Dll1 to the Notch receptors, since the two N-terminal
domains together with the DSL domain are responsible for the
binding of DSL ligands to the Notch receptors [15,21,22]. The
combination of mapping data with the similar phenotypes between
Dll1
E26G mutant embryos and the previously described Dll1 mutant
makes allelism between 59459-2 and Dll1 very likely.
A premature stop codon in Ptprb/VE-PTP leads to early
embryonic lethality in 59468-4 mutants
The 59468-4 mutant exhibits slight cardiac edema (Figure 4a–c).
Genome-wide mapping linked it to a region on Chr 10 between 114
and 116.5 Mbp. We noticed a striking resemblance to the
Figure 1. Schematic diagram depicting the ENU-mutagenesis
screen. Male C57BL/6 inbred mice were treated with ENU and crossed
to FVB/N females to generate 150 G1 founder males. These were
subsequently crossed with FVB/N females and the resulting G2 females
were backcrossed with their G1 father. The offspring (G3) was screened
for disturbed phenotypes at E10.5.
doi:10.1371/journal.pone.0019357.g001
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interval, Ptprb, also known as E-PTP. Ptprb/VE-PTP mutants have
previously been described as being defective in angiogenesis;
vascular remodeling defects lead to a severely inflated pericardial
sac and growth arrest at embryonic day 9.5 [23,24]. Baumer et al.
also report that in their mutants the endocardium fails to attach to
the myocardium, eventually leading to trabeculation defects;
furthermore, they observed failure of intersomitic vessel develop-
ment. These malformations strongly correlate with the expression
pattern of Ptprb/VE-PTP mRNA, which is throughout development
predominantly localized to atrial endothelium[24]. VE-PTPacts by
negatively regulating Tie2, a protein that regulates endothelial cell
proliferation and thus blood vessel remodeling [25].
The Ptprb encoding tyrosine phosphatase receptor b is located
within the region on Chr 10 mentioned above, and sequencing of
its coding regions revealed a T to A transversion at nucleotide
position 2079 (ENSMUST00000020363) (Figure 4D). This
mutation causes a stop codon at the tyrosine at position 445 of
this 1998-amino acid long protein (Figure 4E). This early stop
codon ablates the protein tyrosine phosphatase domain in the C-
terminal part of the protein and likely leads to total loss of protein
function and therefore a null mutant. Allelism between 59468-4
and Ptprb/VE-PTP is not formally proven by these results, but is
highly likely in view of the combination of independent types of
evidence, i.e. similarity of phenotypes and mapping.
Exencephaly in the 59780-4 mutant is caused by a
glutamic acid to glycine substitution in the Sema-domain
of Plexin-B2
A mutant displaying exencephaly (Figure 5A–C) was mapped to
chromosome 15 between 88.0 and 89.4 Mbp. Exons from the
genes located in this segment were sequenced and the Plexin-B2
gene was found to contain an A to G transition only in DNA from
mutants. This mutation predicts a glutamic acid to glycine
substitution at amino acid position 369 E369G (Figure 5D,E).
The membrane receptor Plexin-B2 is expressed in proliferating
granule cell progenitors. Plexins are the receptors for Semaphor-
ins; these ligands are involved in processes underlying prolifera-
tion, differentiation and migration in a variety of tissues [26].
Plexin-B2 mutants have been reported previously; they die at
birth due to neural tube closure defects extending from fore- to
hindbrain. [27,28]. No molecular mechanism explaining this
phenotype has been put forward. In the few mutants of the KO
line that do not show a neural tube closure defect and survive until
after birth, Plexin-B2 has been reported to have a role in
maintaining the balance between differentiation and proliferation
of the granule cells. Loss of this balance in Plexin-B2 mutants was
said to result in over-proliferation of the differentiated granule cells
that migrate into the cerebellum, leading to a severely altered
cerebellar cytoarchitecture [27,28].
The amino acid that is changed in our Plexin-B2
E369mutant is
localized in the Semaphorin-binding domain of the protein
(Fig 5F), which may indicate that the glutamic acid at this position
is essential for the binding of these Semaphorins to the cell surface
receptor Plexin-B2. This possibility has not yet been tested. Given
the combination of independent evidence, allelism of 59780-4 and
Plexin-B2 is very likely, but remains formally unproven.
A leucine to proline substitution in FGF10 leads to
absence of limbs and lungs in Pootloos mutants
The Pootloos mutant (Figure 6) was found on the basis of it lacking
limb buds at E10.5 (Figure 6B,D). Alcian Blue and Alizarin Red
Table 1. Overview of mutants found in this screen (see Table S2 for additional information).
Line
a Phenotype
b Chr Mbp
c Affected gene Mutation Figure Ref.
5120-6B Craniorachischisis 15 71-83.2 Scribble [12]
5120-6C Cardiac edema 10 25-29 Unknown 2D
5120-7 Cardiac edema 17 78–84.5 Ncx1 N874K [13]
5120-8 Open hindbrain 11 115–120 Unknown 2B
59458-3 Craniorachischisis 3 121.6–130.8 Sec24b [12]
59459-2 Situs inversus and short tail 17 5.5–27.5 Dll1 E26G 3
59468-4 Cardiac edema 10 114–116.5 Ptprb Y693X 4
59622-3 Cardiac edema 3 49–76 Unknown 2E
59780-4 NTD fore- and midbrain 15 8–89.4 PlexinB2 E369G 5
Amiko Growth arrest at E9.0 14 24–72 Unknown 2L
Cerbo Cardiac and nuchal edema 2 165–166 Unknown 2I
Flanka Abnormal head, heart, NTD 6 14.1–32.2 Unknown 2K
Koro Cardiac edema 11 3.2–17.6 Unknown 2F
Pootloos No limbs 13 - Fgf10 L91P 6
Linio Cardiac edema 11 94–98.7 Unknown 2C
Nevo Cardiac and nuchal edema 8 77.4–98 Unknown 2J
Salsa Cardiac edema 6 67–71 Unknown 2G
Staartloos Posterior truncation 11 55–66 Wnt3a unknown 7
Zoef Cardiac and nuchal edema 19 33.5–33.8 Unknown 2H
aTrivial name of line.
bMajor distinctive phenotype.
cCandidate interval after mapping.
doi:10.1371/journal.pone.0019357.t001
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theclavicleand anteriorscapula.Inthepelvicregion,a rudimentary
iliac bone was present but the fore- and hind limb bones are absent
(Figure 6C,D). Transverse sections of E11.5 mutant embryos
revealed the presence of primary lung buds, but no outgrowth and
branching of the lungs (Figure 6E,F). This phenotype strikingly
resembles the unique total loss-of-function phenotype of Fgf10
mutants described by Min et al. and Sekine et al. [29,30]. The
mutants described by these authors are also characterized by the
absence of limbs, retaining clavicle, anterior scapula and a
rudimentary iliac bone. They have been reported to die shortly
after birth due to the absence of the lungs [29,30]. After confirming
linkage of the mutation to Fgf10 by limited mapping using a small
number of SNPs, we proceeded by sequencing the Fgf10-coding
region of Pootloos mutants and wildtypes. By exception, in this case
the other candidates in this region were not sequenced. We
identified a T to C transition predicted to cause a leucine to proline
substitution at amino acid position 91 (ENSMUSP00000020363)
(Figure 6H). This amino acid is part of a conserved domain
common to all FGFs, but does not appear to be involved directly
with functions characteristic of FGFs, like interactions with the FGF
receptor or with heparin (see: http://www.ncbi.nlm.nih.gov/
Structure/index.shtml; [31]; Figure 6G). The insertion of a proline
is likely to have a major impact on essential aspects of the protein
structure of the FGF-domain and may cause a total loss-of-function.
The combination of independent evidence from a unique
phenotype, the partial mapping and the presence of the mutation
makes allelism of Fgf10 and Pootloos extremely likely.
Severe axial truncation in the Staartloos mutant
One mutant, named Staartloos, displaying a severe posterior
truncation defect was found in the screen. Homozygous embryos
had no tail, sometimes lacked hind limbs or had fused hind limbs
(sirenomelia), and lacked caudal somites or vertebrae (Figure 7A,B).
Mapping resulted in a candidate interval on chromosome 11
between 55 and 66 Mbp. All genes in this area were sequenced,
but no mutations were found. The phenotype of this mutant line
shows striking resemblances to the previously characterized knock-
out phenotype of one of the genes present in the candidate
interval. Wnt3a mutants have also been described as posteriorly
Figure 2. Mutants identified in a recessive ENU-mutagenesis screen. A wildtype (A) embryo and the phenotypes of mutants indentified in
the screen for which we thus far have not identified the causative mutation (B-L).
doi:10.1371/journal.pone.0019357.g002
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of notochord and tailbud and lack of caudal somites [32,33], based
on failure of axial extension during early development. A striking
phenotype previously reported for other Wnt3a mutant alleles is
the occurrence of a partially duplicated neural tube. In work with
Staartloos embryos, this phenotype has recently also been
demonstrated (J. Deschamps, personal communication). Sequenc-
ing of a Wnt3a cDNA clone from a homozygous mutant, the
coding region of genomic DNA, exon/intron transitions, 59-
untranslated regions neither revealed a mutation. We therefore
crossed the Staartloos mutant with the Wnt3a KO mice [32] to
explore non-complementarity of these two mutations. Double
heterozygous mutant embryos were very similar to Staartloos
mutants (Figure 7B,C), confirming that Staartloos carries a Wnt3a
mutant allele. Possibly Wnt3a levels in the mutant are affected by a
mutation in a regulatory element. Intriguingly, the causative
mutation for the Wnt3a hypomorphic mutant Vestigial tail has never
been reported either. In embryos homozygous for the Vestigial tail
Figure 3. A substitution mutation in Dll1 leads to situs inversus
and posterior truncation. (A) Whole mount view of Dll1
E26G and
wildtype embryos. Note the shorter tail in the mutant. (B) An A-to-G
mutation causing a glutamine-to-glycine substitution in the Dll1
E26G
mutant protein. (C) The mutation is localized in the N1 domain. SP,
signal peptide; N1, N-terminal domain 1; N2, N-terminal domain 2; DSL,
Delta-Serrate-Lag2 domain; EGF repeat, epidermal growth factor-like
repeats; TMD, transmembrane domain; PDZL, PDZ (postsynaptic density
95, PSD-85; discs large, Dlg; zonula occludens-1, ZO-1) ligand motif. (D-I)
H&E stainings on transverse sections at E9.5. The asterisk in E marks
reversed looping compared to wildtype (D). NT, neural tube; Ht, heart.
The arrow in G indicates an ectopic neural tube (F). Irregularly shaped
neural tube (asterisks) and somites (arrows) in Dll1E26G mutants (H,I).
Som, somites; Nc, notochord.
doi:10.1371/journal.pone.0019357.g003
Figure 4. Cardiac edema in a mutant for Ptprb. Comparison of
wildtype (A) and Ptprb mutant embryos (B,C). Note the cardiac edema
in C. Sequence analysis shows a T to A mutation in Ptprb (D). Location
of the Ptprb
Y693X mutation (E).
doi:10.1371/journal.pone.0019357.g004
Figure 5. A mutation in Plexin-B2 leads to exencephaly. Mutant
embryos displaying closure defects throughout the brain region of the
neural tube (A–C). Sequencing revealed an A-to-G point-mutation (D).
Location of the Plexin-B2
E396G mutation (E).
doi:10.1371/journal.pone.0019357.g005
Forward Screen in Mouse
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affects regulation of Wnt3a. Staartloos mutants contain more caudal
vertebrae than Wnt3A KO embryos (Figure 7E-H), suggesting
that the Staartloos mutation represents a hypomorphic condition for
Wnt3a. Allelism of Staartloos with Wnt3a is therefore supported by
four types of evidence: (i) genome-wide mapping; (ii) a phenotype
very similar to that described in two mutant alleles of Wnt3a; (iii) a
failure of the mutant to complement the Wnt3a phenotype.
Therefore Staartloos is almost certainly allelic with Wnt3a.
Seven mutant lines carrying the same mutation
Seven mutants linked to an identical cardiac edema phenotype
mapped in the same region of Chromosome 6 between 67 and
71 Mbp. Compound mutants of several combinations of these
lines all led to the same phenotype, demonstrating that the same
locus was affected. These lines must all have derived from a single
spontaneous mutation present in some of the C57BL/6 mice used
for the ENU injections. We have combined these mutants under
the name Salsa (Table 1 and Fig. 2) and are still in the progress of
identifying the causative mutation.
Affected lung development in two PCP mutants
We identified two mutants in our screen that were characterized
by the neural tube defect craniorachischisis in homozygous mutant
embryos, Sec24b
Krabbel and Scrib
5120-6B; see [12]. In addition to the
defects described above, we observed a lung development defect.
At E17.5, the lungs of both mutants are smaller than those of
wildtypes and the lobes are irregularly shaped (Figure 8A–F), with
a clearly more severe phenotype seen in the Scrib mutant
(Figure 8B,E; compare to Figure 8C,F). As we have shown that
Sec24b is essential for adequate intracellular trafficking of Vangl2
in the neural tube [12], it is tempting to speculate that the lung
Figure 6. A leucine-to-proline substitution in the FGF domain of FGF10 leads to absence of limbs and lungs. Wildtype E10.5 embryo (A)
and mutant embryo (B) displaying lack of limb buds at E10.5. In (A), yellow and orange arrows indicate location of fore and hind limbs (FL, HL),
respectively, and similar arrows indicate in (B) the areas where they would have been expected to appear. (C,D) Comparison by bone stainingof
wildtype (C) and mutant (D) FGF
L91P E15.5 embryos. In the mutant, clavicle (Clav), parts of the scapulae (Sc) and rudimentary iliac bones (Il) are
present, but fore- and hind limb bones are absent. Sequencing revealed a T-to-C mutation (D). (E,F) Histological sections of E11.5 wildtype (E) and
mutant (F) embryos at a thoracic level. ‘Lu’ in (F) indicates the lungs and arrows in G indicate the undeveloped lung buds in the mutant embryo. (G)
Schematic representation of the alteration in the FGF protein, based on the detected mutation (H).
doi:10.1371/journal.pone.0019357.g006
Figure 7. Genetic interaction of Staartloos with Wnt3a. (A–D) Whole mount views of wildtype (A), Staartloos homozygous (B), Staartloos/Wnt3a
transheterozygous (C) and Wnt3a KO mutant embryos (D). (E–H) Bone stainings of wildtype (E), Staartloos homozygous (F), Staartloos/Wnt3a double
heterozygous (G) and Wnt3a KO mutants (H).
doi:10.1371/journal.pone.0019357.g007
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Vangl2 at the cell membrane.
Discussion
In this phenotype-based screen we have identified a series of
new mutant alleles causing disrupted embryonic development. In
some cases these new mutants represent unexpected genotype-
phenotype associations while in other cases comparatively subtle
mutations in previously studied genes reveal new findings at a
molecular level.
The efficiency of our screen has been of similar efficiency
compared to the comparable screens in the Anderson group (e.g.,
[3][10]). Kasarskis et al. [10] mention that 5–10% of founders
tested showed a reproducible affected phenotype, and our data are
in the same range. Exact meaningful numbers are difficult to give,
since about 35 of the 150 founder lines were abandoned when we
deemed the phenotype insufficiently reproducible, or when the
initial mapping yielded unclear data; some of these lines may have
represented real mutants. Of about 115 founders at least 4 G3
litters containing at least 30 embryos were analyzed.
We have no explanation for the fact that so few mutants
identified by us display a defect linked to Sonic hedgehog
signaling, as was the case in the screens mentioned above. Many
of our mutants were identified by cardiac edema. This perhaps
reflects the stage that we chose for the initial analysis of potentially
mutant embryos, which is 1–2 days after the embryo becomes
dependent on a functioning beating heart. In addition, cardiac
edema is an endpoint of many different lethal defects.
Unexpected findings included the identification of a Scrib allele
that must have arisen due to a ‘spontaneous’ (i.e. not ENU-
induced) mutation of an FVB/N female, and the confusing
findings with the Salsa mutant. In this case mutations were found
that initially appeared to explain the phenotype; however the
mutations were also present in some of the heterozygotes and must
have been derived from genetic variation in the CB57/B6 mice
used. This underscores the importance of checking the genetic
purity of the mice strain used for the mutagenesis.
Figure 8. Affected lung development in the two PCP mutants obtained in our screen. (A–C) Dorsal and (D–E) ventral views of the lungs
and hearts of (A,D) wildtype (B,E) Scrib and (C,F) Sec24b mutant embryos. Note the reduction in size of the mutant lung, in particular that of Scrib. (G–I)
Sections of wildtype (G), Scrib mutant (H) and Sec24b mutant (I) lungs at E13.5. Ht and Lu (D) mark the heart and Lungs respectively, lumina (G) are
labeled ‘Lum’.
doi:10.1371/journal.pone.0019357.g008
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Scribble, Vangl2 and Sec24b have all been linked to the planar cell
polarity (PCP) pathway that regulates the polarity in the plane of a sheet
of epithelial cells and controls convergent extension of a tissue [12];
reviewed by [34]. The involvement of PCP signaling in lung
development is supported by the following data: (i) In vitro lung
branching is under the control of the downstream PCP factor RhoA
[35]. (ii) Lung defects have been reported in mouse mutants for the
‘non-canonical’ Wnt5a g e n e[ 3 6 ] .F u r t h e r m o r e ,o v e r -a n de c t o p i c
expression of Wnt5a in a cultured chick lung explant model confirmed
its importance for lung development [37] and (iii) mutants for the PCP-
related gen Fat4[38] display branching defects in the kidney, an organ
that shares similar signaling pathways with the lung and other organs
containing branching tubes. These observations make it worthwhile
further investigating the possible role of noncanonical Wnt signaling in
lung development (see also: [39]). Recently Yates et al. [40] for the first
time linked the core PCP pathway to lung development; they showed
an abnormal size and shape of the lung lobes in Celsr1 and Vangl2
mutants. Both mutants have defects in lung branching and
abnormalities of cytoskeletal architecture, as well as a reduced number
and width of the airway lumina. The phenotype was confirmed in a
lung explant model and a reduced response to FGF10 was
demonstrated in this context. In vitro activation of Rho kinase restores
lung branching in the Vangl2 and Celsr1 mutants. In addition to this,
Celsr1 has a specific role in bifurcation of the lung buds. These authors
also mention that they found a similar phenotype in their Scribble mutant
[40]. We found, in addition to the small and irregular lung lobes, a
disturbed cellular organization in the lumina in the Sec24b and Scribble
mutants (Figure 3H,I), comparable to the double layers of epithelial cells
in the Celsr1 and Vangl2 mutants [40]. Possibly, Sec24band Scribblealso
direct lung development through the PCP pathway. The strong
phenotype in the Scrib
5120-6B mutant opens the possibility that there
might be another crucial role for Scribble in lung development.
Conclusions
While reverse genetics (i.e., gene targeting technology) is powerful
in that theoretically any desired genotype can be created, forward
genetics is valuable as a parallel system and has a number of
advantages: (i) the unbiased approach to identify genes of unknown
function involved in development; (ii) the identification of single
amino acids changes that alter protein function and (iii) the
identification of novel phenotypes and functions of genes of known
function that bypass lethality by the introduction of hypomorphic
substitution mutations. A case in point for (i) is the Sec24b mutant,
where we found the surprising link between Sec24b-dependent
COPII-coated endoplasmic reticulum to Golgi protein transport,
Vangl2 trafficking and PCP[12]. Examples of (ii) are the various
mutants described in this paper in which a single missense mutation
leads to a very strong phenotype, demonstrating in vivo the
biochemical essentiality of the residue in question.
Recently, technological advances including ‘Next Generation
Sequencing’ [41] have further reduced the efforts needed to isolate
mutations. This will add greatly to the potential of ENU-mutagenesis
screens, since the causative mutations can be found more rapidly. It
should be possible to pinpoint the elusive mutations in Staartloos and
vestigial tail Wnt3aalleles in a relatively straight-forward manner,
although this will also require analysis of reporter construct to test
directly the mutations found.
Materials and Methods
Ethics statement
Animal experiments were conducted under the approval of the
‘dierexperimentencommissie’(animal care committee) of the Royal
Netherlands Academy of Arts and Sciences (KNAW), (permit
numbers HL03.0204, HL04.0201, HL05.0201 and HL05.0203).
ENU-mutagenesis
40 C57BL/6 males were injected three times intraperitoneally
with 60–80 mg/kg bodyweight ethyl-N-nitrosourea (ENU) with
one-week intervals. After a recovery period of 8-10 weeks the mice
were crossed with FVB/N females to generate 150 G1 males.
These ‘founder’ males were subsequently crossed with FVB/N to
generate G2 females, who were crossed with their G1 father to
generate G3 embryos. Each of these embryos is expected to be
homozygous for 6.25% of the mutations initially induced in the
C57BL/6 mice. These G3 litters were collected at E10.5 and
screened for any perceptible malformations. DNA of the mutant
and their littermates was isolated for mapping. In rather numerous
cases where a presumptive mutant was identified initially on the
basis of severe cardiac edema at E10.5, we did further isolations at
E9.5, which often allowed more relevant observations on the
specific nature of the phenotype and also to avoid possible loss of
embryos due to resorption. We screened a minimum of four G3
litters (of at least six, and on average more than eight embryos)
produced by each G1 male. All mutant lines described in this
paper are available from the authors to interested scientists. Lines
were maintained by crossing against FVB/N until the mutation
had been mapped. The exception was with the Scrib
5120-6b line that
arose from a mutation in a FVB/N mouse used for outbreeding
[12].
DNA isolation
DNA was collected from embryos, yolk sacs (,E9.0) or ear
clippings. The DNA was isolated by overnight incubation at 55uC
while rotating in lysis buffer [TENS: 100 mMTris-HCl pH 8–8.5,
200 mMNaCl, 0.2% sodium dodecyl sulphate and 5 mMEthyle-
nediaminetetraacetic acid (EDTA)] supplemented with 100 mg/ml
proteinase K. From ear clippings hair was removed by
centrifugation for 15 min at 12,000 x g. DNA was precipitated
by adding 1 volume of 100% isopropanol at room temperature
and vortexing for 5 min. To dissolve, the pellet was incubated with
TE buffer (10 mMTris pH 7.5, 0.1 mM EDTA) overnight at
55uC while rotating. DNA was stored at 4uC.
Genetic mapping and genotyping
A panel of 192 SNPs discriminating between FVB/NJ and
C57BL/6 DNA alleles was designed (see Table S1). These SNPs
are spread equally over the genome and were used for initial
genome-wide mapping using approximately 8 mutant and 8
wildtype or heterozygous DNAs isolated from each mutant line.
Additional mapping using extra SNPs in the identified regions
(http://phenome.jax.org/pub-cgi/phenome/mpdcgi?rtn=docs/home)
reduced the candidate regions to intervals small enough to start
sequencing coding regions (see Table 1). In a limited number of
cases we gave priority to genes in this interval that had been
previously characterized and shown to have phenotypes resem-
bling our mutant. Mice and embryos were genotyped by PCR and
sequencing of the mutation or SNPs in the identified interval.
Generally between 70 and 100% of the genes in the candidate
interval was sequenced, depending on the likeliness that found
mutations corresponded to the phenotype observed. Table S2
summarizes mapping data for mutant lines discussed in this paper.
Sequence analysis
To amplify SNPs and exons of genes, a so-called touch-down
program was used: 19 at 94uC followed by 12 cycles of: [300 at
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70uC], followed by 20 cycles of: [300 at 92uC; 300 at 58uC; 300 at
72uC] followed by a final step of 39 at 72uC. GoTaq polymerase
(Promega) was used according to the supplier’s instructions. Gene-
specific primers were designed using software accessible at http://
primers.niob.knaw.nl/ and http://limstill.niob.knaw.nl/.
PCR products were diluted and sequenced using BigDye v3.1
terminator (Applied Biosystems). The following protocol was used:
19 at 95uC, 30 cycles of 100 at 95uC, 50 at 50uC, 29 at 60uC. After
the sequence reaction, the samples were purified using Sephadex
G-50 Superfine (Sigma) or by ethanol/EDTA/Sodium Acetate
precipitation. Sequencing was done at the Hubrecht institute
sequencing facility with a 96-capillary 3730XL DNA analyzer
(Applied Biosystems), using the standard RapidSeq protocol on
36 cm array. Mutations were identified using software based on
Polyphred [42].
Miscellaneous procedures
Bone stainings were performed exactly as described by
Beverdam et al. [43]. Hematoxylin and eosin staining were done
according to standard procedures.
Supporting Information
Table S1 A 192-genome wide SNP panel.Listing of SNPs
used in the genome-wide panel. First column, arbitrary
number for identification; second column, rs numbers allowing
retrieval from common databases (e.g. http://www.ncbi.nlm.nih.
gov/projects/SNP/snp_blastByOrg.cgi); third column (‘Chr’),
chromosome number; fourth and fifth columns provide expected
nucleotide for C57Bl/6 and FVB/N, respectively.
(XLS)
Table S2 Mapping coordinates of mutant lines. Rs
numbers correspond to the SNP database For each mutant the
borders of the candidate region is given by the name (rs number)
of the SNP (see http://www.ncbi.nlm.nih.gov/projects/SNP/
snp_blastByOrg.cgi) as well as, in the last two columns, the
chromosomal coordinates.
(DOCX)
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